Effects of entecavir, tenofovir and telbivudine treatment on renal functions in chronic hepatitis B patients

KARA A. V., Yildirim Y., ÖZÇİÇEK F., Aldemir M. N., Arslan Y. K., Bayan K., ...Daha Fazla

ACTA GASTRO-ENTEROLOGICA BELGICA, cilt.82, sa.2, ss.273-277, 2019 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 82 Sayı: 2
  • Basım Tarihi: 2019
  • Dergi Adı: ACTA GASTRO-ENTEROLOGICA BELGICA
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.273-277
  • Anahtar Kelimeler: Chronic hepatitis B, estimated glomerular filtration rate, entecavir, tenofovir, telbivudine, GLOMERULAR-FILTRATION-RATE, DISOPROXIL FUMARATE, ANTIVIRAL THERAPY, SAFETY, INFECTION, COHORT, MONOTHERAPY, ADULTS
  • Çukurova Üniversitesi Adresli: Hayır

Özet

Background and study aims : The aim of this study was to enlighten the controversy about the renal safety of entecavir, tenofovir, and telbivudine treatments in chronic hepatitis B (CHB) patients by comparing these treatments in real-world conditions.